LONA

LeonaBio, Inc.

NASDAQ: LONA · HEALTHCARE · BIOTECHNOLOGY

$4.96

+1.43% today

Updated 2026-10-28

Market cap

$45.60M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-20.19

Dividend yield

—

52W range

$2 – $14

Volume

0.2M

Market cap

$45.60M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-20.19

Dividend yield

—

52W range

$2 – $14

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.5

Quality

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

-8.2

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →270 stocks currently score above 75

Price targets

Analyst target

$17.33

+249.40%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

+ Debt/equity 0.02x — low leverage

Risks

- Piotroski 2/9 — weak financial health

- Altman Z -8.19 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-16.96M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-95.64M	$-117.67M	$-96.94M	$-105.61M	$-19.01M
EPS	—	—	—	—	$-20.19
Free cash flow	$-73.61M	$-101.06M	$-97.20M	$-45.73M	$-16.96M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
LONA	$45.60M	32	4.3	3.0	5.0	6.5	—	Avoid
LLY	$1.12T	76	9.3	10.0	5.0	6.0	—	Strong Buy
JNJ	$615.87B	57	4.7	8.5	2.7	5.5	-83.05%	Buy
ABBV	$504.37B	73	6.7	8.5	4.0	5.0	-86.73%	Strong Buy
UNH	$360.32B	62	6.7	6.0	4.7	5.5	-25.92%	Buy
MRK	$360.08B	36	4.0	4.5	2.0	5.0	-73.68%	Hold

Smart narrative

LeonaBio, Inc. trades at $4.96. Our Smart Value Score of 32/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -8.19, it sits in the distress.

Frequently asked questions

What is LeonaBio, Inc.'s stock price?

LeonaBio, Inc. (LONA) trades at $4.96.

Is LeonaBio, Inc. overvalued?

LeonaBio, Inc. carries a Smart Value Score of 32/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of LeonaBio, Inc. (LONA)?

The 12-month analyst consensus target is $17.33, about 249.4% above the current $4.96. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

LeonaBio, Inc.'s Altman Z-Score is -8.19, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-298.80%

Beta2.12

50D MA$6.35

200D MA$7.56

Shares out0.01B

Float0.00B

Short ratio—

Avg volume0.2M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

LONA vs LLY →LONA vs JNJ →LONA vs ABBV →Stock screener →